|
ARWR Arrowhead Pharmaceuticals Inc 879407 |
| Balance Sheet |
|
Current Assets
|
$1,671,411,000.00 |
|
Assets
|
$2,112,013,000.00 |
|
Current Liabilities
|
$283,346,000.00 |
|
Equity
|
$465,529,000.00 |
|
Shares Out
|
141135000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-79,546,000.00 |
|
Investing Cash Flow
|
$-874,341,000.00 |
| Market Analysis |
Market Cap
|
$12,345,078,450.00 |
|
Price
|
$87.47 |
|
BVPS
|
3.30 |
|
PB
|
26.51 |
|
EPS
|
-1.36 |
|
PS
|
41.01 |
|
FCF
|
$-88,113,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:10 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-05 |
0.22 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.93 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-1.26 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-25 |
-0.01 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ARWR documents filed with the SEC.
ARWR Filings
Clear
